[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 325
Citations 0
Capitol Health Call
May 14, 2014

Seeking Clarity on FDA Medical Apps Oversight

JAMA. 2014;311(18):1847. doi:10.1001/jama.2014.5034

A bipartisan group of senators is seeking greater clarity and transparency from the Food and Drug Administration (FDA) regarding its policy overseeing certain mobile medical applications, or apps.

On September 23, 2013, the FDA issued its final guidance, saying it intended to not use its regulatory oversight for a majority of mobile medical apps, as they pose minimal risk to consumers. The agency did say it intended to use its oversight for medical apps that present a risk to patients if the apps do not work as intended.

First Page Preview View Large
First page PDF preview
First page PDF preview